The Efficacy and Safety of Endo-Radiofrequency for the Treatment of Hidradenitis Suppurativa Publisher



Behrangi E¹ ; Atefi N¹ ; Mireshghollah P¹ ; Goodarzi A¹ ; Dehghani A¹ ; Zare Dehnavi A² ; Roohaninasab M¹ ; Dilmaghani S¹ ; Lotfi E³ Show Affiliations
Source: Skin Research and Technology Published:2023

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic and recurrent disease of the axilla and groin with inflammatory lesions. There is no definitive medication or intervention to cure the disease. Radiofrequency (RF) is a modality to destroy the lesions by transferring heat into the skin. To date, few studies have been conducted to evaluate the efficacy and safety of RF at HS. Methods: This 9-month, prospective, nonrandomized, and single-blinded study is a clinical trial conducted in 10 patients with refractory HS. In all patients, the initial grade of HS was evaluated. The procedure involved treating HS of the axilla with a endo-RF wave device. Post-treatment evaluation included: determination of the severity of the disease by a blinded dermatologist, the degree of patient satisfaction, tolerability in each patient, and complications of the procedure. We also evaluate the recurrence of the disease during a 6-month follow-up. Results: The satisfaction level after the intervention among under-studied cases was excellent and good in six of cases. There was a significant difference in comparing the grading score of patients before and 3 months after receiving RF (P-value: 0.01). Regarding tolerability, eight of the patients could tolerate it. We had no complication after the intervention and four cases had not recurrence during a 6-month follow-up. Conclusion: Endo-RF is an effective and safe modality for treating HS however to prevent the recurrence, periodic therapy sessions are needed. © 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd.